Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Nature Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 14520364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study.

  2003cited by this paper
• Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.

  2003cited by this paper
• Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis.

  2002cited by this paper
• Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

  2001cited by this paper
• Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.

  2000cited by this paper
• Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

  2000cited by this paper
• Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.

  1999cited by this paper
• Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.

  1998cited by this paper
• Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

  1998cited by this paper
• Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.

  1997cited by this paper
• Role of cytokines in rheumatoid arthritis.

  1996cited by this paper
• Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis.

  1995cited by this paper
• Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

  1995cited by this paper
• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

  1994cited by this paper
• Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.

  1994cited by this paper
• Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.

  1994cited by this paper
• Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.

  1993cited by this paper
• Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

  1992cited by this paper
• Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.

  1991cited by this paper
• Expression of granulocyte‐macrophage colony‐stimulating factor in rheumatoid arthritis: Regulation by tumor necrosis factor‐α

  1991cited by this paper
• Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

  1991cited by this paper
• Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

  1989cited by this paper
• Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

  1989cited by this paper
• Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

  1988cited by this paper
• Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

  1987cited by this paper
• Structure and expression of human B cell stimulatory factor‐2 (BSF‐2/IL‐6) gene.

  1987cited by this paper
• Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

  1984cited by this paper
• Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity.

  1983cited by this paper
• Structure and expression of a cloned cDNA for human interleukin-2

  1983cited by this paper
• Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis.

  1982cited by this paper
• RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATION

  1981cited by this paper

• Rapid, Single-Step Monitoring of Monoclonal Antibody Bioavailability by Using a TNF-α-Based Multiepitope DNA Nanoswitch

  2025cites this paper
• Efficacy, Safety, and Immunogenicity of Biosimilar Adalimumab Advixa® Compared With Reference Product Humira® in Patients With Rheumatoid Arthritis in Bangladesh

  2025cites this paper
• MIS-C pathogenesis: immune dysregulation & viral triggers

  2025influential citation
• Huntingtin-Interacting Protein 1-Related (HIP1R) Regulates Rheumatoid Arthritis Synovial Fibroblast Invasiveness

  2025cites this paper
• Unveiling the synergistic impact of cocktail nanohyalurosomes encapsulating berberine and dexamethasone in managing rheumatoid arthritis: in-vitro evaluation and biological studies

  2025cites this paper
• Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence

  2025cites this paper
• Nanotechnology-driven strategies for gene therapy of arthritis

  2025cites this paper
• Pharmacogenomics of TNF inhibitors

  2025cites this paper
• Challenges in tendon–bone healing: emphasizing inflammatory modulation mechanisms and treatment

  2024cites this paper
• Therapeutic potential of Leea asiatica: Chemical isolation and validation of ethnomedicinal claims through in vitro and in silico assessment of antioxidant and anti-inflammatory properties

  2024cites this paper
• KIF1C and new Huntingtin-interacting protein 1 binding proteins regulate rheumatoid arthritis fibroblast-like synoviocytes’ phenotypes

  2024cites this paper
• Editorial: Women in cytokines and soluble mediators in immunity

  2024cites this paper
• Pharmacogenetics of therapies in rheumatoid arthritis: An update.

  2024cites this paper
• Tecoma stans Floral Extract-Based Biosynthesis for Enhanced Surface Plasmon-Coupled Emission and a Preliminary Study on Fluoroimmunoassay.

  2024cites this paper
• Bioinformatic-based Study to Investigate the Structure and Function of Pro-inflammatory Cytokines TNFα and IL-6 Involved in the Pathogenesis of COVID-19

  2024cites this paper
• Rapid Production of Native and Mirror-Image Tumor Necrosis Factor-α Enabled by Automated Flow Peptide Synthesis Technology.

  2024cites this paper
• Perispinal etanercept stroke trial design: PESTO and beyond

  2024cites this paper
• Determination of adalimumab by HPLC with fluorescence detection using the König reaction.

  2024cites this paper
• Increased expression of IL-1β in adipose tissue in obesity influences the development of colon cancer by promoting inflammation

  2024cites this paper
• Proceedings of the 1st Symposium “Autoimmune Diseases: Clinical Unmet Needs in Systemic Autoimmune Diseases Guide Clinical, Translational and Basic Research”

  2024cites this paper
• Melatonin hyalurosomes in collagen thermosensitive gel as a potential repurposing approach for rheumatoid arthritis management via the intra-articular route.

  2024cites this paper
• Are TNF inhibitors still the agent of choice for RA?

  2023influential citation
• Computational analyses of the interactome between TNF and TNFR superfamilies

  2023cites this paper
• MTHFR c.665C>T and c.1298A>C Polymorphisms in Tailoring Personalized Anti-TNF-α Therapy for Rheumatoid Arthritis

  2023cites this paper
• Synthesis and applications of mirror-image proteins

  2023cites this paper
• Molecular Peptide Grafting as a Tool to Create Novel Protein Therapeutics

  2023cites this paper
• Efficacy and safety of IL inhibitors, TNF-α inhibitors, and JAK inhibitors in patients with ankylosing spondylitis: a systematic review and Bayesian network meta-analysis

  2023cites this paper
• Hyaluronan promotes intracellular ROS production and apoptosis in TNFα-stimulated neutrophils

  2023cites this paper
• Treatments for early-stage Dupuytren’s disease: an evidence-based approach

  2023cites this paper
• Increased contractile activity and dilation of popliteal lymphatic vessels in the TNF-α-overexpressing TNFΔARE/+ arthritic mouse.

  2023cites this paper
• 25 years of biologic DMARDs in rheumatology

  2023cites this paper
• Mechanistic insight on the role of iRhom2-TNF-α-BAFF signaling pathway in various autoimmune disorders.

  2023cites this paper
• A natural goldmine of binding proteins and soluble receptors simplified their translation to blockbuster drugs, all in one decade

  2023cites this paper
• Rheumatoid arthritis: Evolving recognition of a common disease.

  2022cites this paper
• Death by TNF: a road to inflammation

  2022cites this paper
• Chronic Fatigue Exhibits Heterogeneous Autoimmunity Characteristics Which Reflect Etiology

  2022cites this paper
• Prevalence and predictors of atlanto-axial subluxation in rheumatoid arthritis after 12-years' follow-up (ESPOIR Cohort).

  2022cites this paper
• Improving dexamethasone drug loading and efficacy in treating arthritis through a lipophilic prodrug entrapped into PLGA-PEG nanoparticles

  2022cites this paper
• Establishment and verification of a nomogram and a preliminary study on predicting the clinical response of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) in rheumatoid arthritis patients

  2022cites this paper
• Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential

  2022cites this paper
• Development and Evaluation of Novel Leflunomide SPION Bioemulsomes for the Intra-Articular Treatment of Arthritis

  2022cites this paper
• Hyaluronic acid coated Teriflunomide (A771726) Loaded Lipid Carriers for the Oral Management of Rheumatoid Arthritis.

  2022cites this paper
• Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis

  2022cites this paper
• TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease

  2022cites this paper
• The Effects of Exercise on Aging-Induced Exaggerated Cytokine Responses: An Interdisciplinary Discussion

  2022cites this paper
• Long-term clinical results from 10 years follow-up after radiosynoviorthesis: a prospective observational study.

  2022cites this paper
• Mannan-Binding Lectin Deficiency Limits Inflammation-induced Myeloid-Derived Suppressor Cells Expansion via Modulating Tumor Necrosis Factor Alpha-triggered Apoptosis

  2022cites this paper
• Neuroinflammation-mediated mitochondrial dysregulation involved in postoperative cognitive dysfunction.

  2021cites this paper
• Mitochondrial signals regulate ER size and TNF production in rheumatoid arthritis

  2021cites this paper
• Epidemiology and Long-term Sequelae of Pediatric Uveitis

  2021cites this paper
• Bclaf1 regulates c‐FLIP expression and protects cells from TNF‐induced apoptosis and tissue injury

  2021cites this paper
• TNF-α in Uveitis: From Bench to Clinic

  2021cites this paper
• Ischemic Heart Disease and Rheumatoid Arthritis—Two Conditions, the Same Background

  2021cites this paper
• Immunosuppression in Rheumatologic and Auto-immune Disease.

  2021cites this paper
• Targeting thymidine phosphorylase as a potential therapy for bone loss associated with periprosthetic osteolysis

  2021cites this paper
• Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity

  2021cites this paper
• Therapeutic effect of various ginsenosides on rheumatoid arthritis

  2021cites this paper
• Identification of differentially expressed genes and pathways crosstalk analysis in Rheumatoid and Osteoarthritis using next-generation sequencing and protein-protein networks

  2021cites this paper
• Anti-TNF treatment corrects IFN-γ-dependent proinflammatory signatures in Blau syndrome patient-derived macrophages.

  2021cites this paper
• Triggers of Cardiovascular Diseases in Rheumatoid Arthritis.

  2021cites this paper
• Potential application of immunotherapy for modulation of pulp inflammation: opportunities for Vital Pulp Treatment.

  2021cites this paper
• Synergistic and receptor-mediated targeting of arthritic joints via intra-articular injectable smart hydrogels containing leflunomide-loaded lipid nanocarriers

  2021cites this paper
• Infliximab for the treatment of patients with checkpoint inhibitor–associated acute tubular interstitial nephritis

  2021cites this paper
• High Concentrations of Etanercept Reduce Human Islet Function and Integrity

  2021cites this paper
• Attenuation of rheumatoid arthritis through the inhibition of caspase3/GSDME-mediated pyroptosis induced by TNF-α.

  2021cites this paper
• Effect of Anti-Rheumatic Treatment on the Periodontal Condition of Rheumatoid Arthritis Patients

  2021cites this paper
• The Expanding Role of Chemistry in Optimizing Proteins for Human Health Applications.

  2021cites this paper
• Roles of IL‐1 and IL‐10 family cytokines in the progression of systemic lupus erythematosus: Friends or foes?

  2021cites this paper
• A shedding soluble form of interleukin-17 receptor D exacerbates collagen-induced arthritis through facilitating TNF-α-dependent receptor clustering

  2020cites this paper
• An Artificial Intelligence Characterised Functional Ingredient, Derived from Rice, Inhibits TNF-α and Significantly Improves Physical Strength in an Inflammaging Population

  2020cites this paper
• The science and medicine of human immunology

  2020cites this paper
• Computational engineering the binding affinity of Adalimumab monoclonal antibody for designing potential biosimilar candidate.

  2020cites this paper
• Targeted Combination of Antioxidative and Anti-Inflammatory Therapy of Rheumatoid Arthritis using Multifunctional Dendrimer-Entrapped Gold Nanoparticles as a Platform.

  2020cites this paper
• 3,6’-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation

  2020cites this paper
• Lymphatic Distribution of Etanercept Following Intravenous and Subcutaneous Delivery to Rats

  2020cites this paper
• Development and application of an antibody that binds to interleukin-1β of various mammalian species for the treatment of inflammatory diseases.

  2020cites this paper
• Identification of potential TNF-α inhibitors: from in silico to in vitro studies

  2020cites this paper
• Analyzing glycans cleaved from a biotherapeutic protein using ultrahigh-resolution ion mobility spectrometry together with cryogenic ion spectroscopy.

  2020cites this paper
• Dereplication and quantification of the ethanol extract of Miconia albicans (melastomaceae) by HPLC-DAD-ESI-/MS/MS, and assessment of its anti-hyperalgesic and anti-inflammatory profiles in a mice arthritis-like model: Evidence for involvement of TNF-α, IL-1β and IL-6.

  2020cites this paper
• PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice.

  2020cites this paper
• Plasma membrane receptors of tissue macrophages: functions and role in pathology

  2020cites this paper
• A computational model for understanding the oligomerization mechanisms of TNF receptor superfamily

  2020cites this paper
• Important determinants of the patient choice between TNF- vs. non-TNF Biologic disease-modifying anti-rheumatic drugs (DMARDs) for active rheumatoid arthritis (RA).

  2020cites this paper
• Adipose-Derived Molecules–Untouched Horizons in Alzheimer’s Disease Biology

  2020cites this paper
• A Systematic Test of Receptor Binding Kinetics for Ligands in Tumor Necrosis Factor Superfamily by Computational Simulations

  2020cites this paper
• Association of Apolipoprotein E Polymorphism with Adipokines and Cardiovascular Disease Risk in Rheumatoid Arthritis Patients

  2020cites this paper
• The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape

  2020cites this paper
• The CD95/CD95L Signaling Pathway: A Role in Carcinogenesis

  2020cites this paper
• The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19

  2020cites this paper
• FGF-7 facilitates the process of psoriasis by inducing TNF-α expression in HaCaT cells.

  2019cites this paper
• Systemic Tumor Necrosis Factor-Alpha Trajectories Relate to Brain Health in Typically Aging Older Adults.

  2019cites this paper
• Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α

  2019cites this paper
• AB0447 BIOLOGICAL THERAPY AND RADIOSYNOVIORTHESIS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS

  2019cites this paper
• Cross-talk between guanidinoacetate neurotoxicity, memory and possible neuroprotective role of creatine.

  2019cites this paper
• TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells

  2019cites this paper
• The Mononuclear Phagocytic System. Generation of Diversity

  2019cites this paper
• AB0446 REAL-LIFE USE OF BARICITINIB IN RHEUMATOID ARTHRITIS: A MULTICENTER OBSERVATIONAL STUDY OF 150 PATIENTS

  2019cites this paper
• New therapies in development for the management of non‐infectious uveitis: A review

  2019cites this paper
• The In Vitro Immunomodulatory Effects Of Gold Nanoparticles Synthesized From Hypoxis hemerocallidea Aqueous Extract And Hypoxoside On Macrophage And Natural Killer Cells

  2019cites this paper
• Flip‐flops of natural killer cells in autoimmune diseases versus cancers: Immunologic axis

  2019cites this paper